Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

AstraZeneca500 enrolled

Overview

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Infection in ICU

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay * Hospital-acquired infections accounting for eligibility are: * nosocomial pneumonia (including ventilator-associated pneumonia) * bacteremia * intra-abdominal infections * urosepsis

Outcomes

Secondary Outcomes

the frequency of appropriate antibiotic therapy (defined as the use of antibiotic(s) with "in vitro" efficacy against the identified pathogens responsible for the infection)

the frequency of "the strategy of de-escalation" according to the culture results

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.